Growth Metrics

Evolent Health (EVH) Liabilities and Shareholders Equity (2016 - 2025)

Evolent Health (EVH) has 11 years of Liabilities and Shareholders Equity data on record, last reported at $2.5 billion in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 1.93% year-over-year to $2.5 billion; the TTM value through Dec 2025 reached $7.6 billion, down 25.54%, while the annual FY2024 figure was $2.5 billion, 5.07% down from the prior year.
  • Liabilities and Shareholders Equity reached $2.5 billion in Q3 2025 per EVH's latest filing, roughly flat from $2.5 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.7 billion in Q4 2023 and bottomed at $1.3 billion in Q2 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $2.2 billion, with a median of $2.5 billion recorded in 2024.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 10.01% in 2021, then soared 102.99% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.4 billion in 2021, then increased by 28.03% to $1.8 billion in 2022, then soared by 47.49% to $2.7 billion in 2023, then fell by 5.07% to $2.5 billion in 2024, then decreased by 3.57% to $2.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $2.5 billion in Q3 2025, $2.5 billion in Q2 2025, and $2.7 billion in Q1 2025.